NCI Renews Mayo Clinic Cancer Center Support Grant, Extends Comprehensive Status
Posted on: Monday, 6 July 2009, 15:11 CDT
The NCI Cancer Center Support Grant award to MCCC totals more than
"The NCI renewal of Mayo's Cancer Center Support Grant ensures the continuity of research programs that contribute to improved medical options for cancer patients," Dr. Diasio says. "This NCI grant is key in enabling Mayo Clinic to continue delivering outstanding care for its cancer patients."
The MCCC is headquartered in
"The NCI recognized the Mayo Clinic Cancer Center for excellence in basic and clinical research, and for our contributions to cancer prevention, control and population sciences," Dr. Diasio says. "This award enables Mayo cancer researchers on all three of our campuses to build upon knowledge that leads to changes in medical practice which means improved treatment opportunities for our patients."
Within its scope as a NCI-designated comprehensive cancer center, the MCCC designs and develops translational clinical studies that arise from collaborations between scientists and physicians.
The 450 scientists and physicians of the MCCC faculty across all three sites are organized into programs that focus on 12 key cancer research themes. They include Women's Cancers, Neuro-Oncology, Hematologic (bloodborne) Malignancies, Gene and Virus Therapy, Developmental Therapeutics, Genetic Epidemiology and Risk Assessment, Immunology and Immunotherapy, Gastrointestinal Cancers, Prostate Cancer, Cell Biology, Cancer Imaging, and Cancer Prevention and Control.
About Mayo Clinic
Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in
SOURCE Mayo Clinic
Source: PR Newswire
Related Articles
- Clinical Center of Serbia, Institute for Cardiovascular Diseases Treats First Patient in Trial of Pioneering Stem Cell-Derived Therapy for Heart Failure
- Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients
- Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience
- Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery
- Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
- Mayo Clinic, McMaster University Research Review Shows Internet-Based Instruction Effective for Teaching Health Care Professionals
- Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led By Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
- Mayo Clinic's Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
- Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
- BioServe Selected By Specialized Clinical Center of Research for Study on Thoracic Aortic Disease
User Comments (0)

RSS Feeds